KMT2A and acute lymphoblastic leukemia: In conclusion, the successful outcomes in this case serve as a preliminary indication of applicability of the VCA regimen in controlling rapid disease progression in B-ALL patients with MLL-AF4 who experience EMR post allo-HCT, thereby providing an opportunity for subsequent treatment.